Interleukin Genetics Inc

Type: Company
Name: Interleukin Genetics Inc
First reported 15 hours ago - Updated 4 hours ago - 3 reports

TRACON Pharmaceuticals, Inc. : TRACON Pharmaceuticals Completes $27 Million Fi...

TRACON Pharmaceuticals Completes $27 Million Financing and Expands Management Team and Board of Directors SAN DIEGO, Sept. 22, 2014 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization ... [Published Investegate - 14 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 2 reports

Interleukin Genetics to Participate in Upcoming Investor and Scientific Events

Interleukin Genetics, Inc. ( OTCQB:ILIU ) announced today that Dr. KennethS. Kornman, Chief Executive Officer, will participate in the followingupcoming investor and scientific events:BTIG’s Inaugural Emerging Technologies in Healthcare DiagnosticsSymposium, ... [Published CBS Detroit - 15 hours ago]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Interleukin CFO bids adieu

16:21 ET | About: Interleukin Genetics, Inc. (ILIU)Interleukin Genetics (OTCQB:ILIU +4%) CFO Eliot M. Lurier resigns effective September 5, 2014 to pursue a position at a Boston area academic institution.Sent to 74 people who get email alerts on ILIU ... [Published Seeking Alpha - Aug 25 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Interleukin Genetics Inc. Reports Second Quarter 2014 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal second quarter ended June 30, 2014.“The utilization of our PerioPredict™ genetic test in the dental office is progressing ... [Published BioSpace - Aug 14 2014]
First reported Aug 13 2014 - Updated Aug 14 2014 - 1 reports

Interleukin Genetics Reports Second Quarter 2014 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal second quarter ended June 30, 2014. “The utilization of our PerioPredict™ genetic test in the dental office is progressing ... [Published Business Wire Health News - Aug 13 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Interleukin Genetics, (ILIU) Releases Quarterly Earnings Results, Meets Expectations

Interleukin Genetics, (NASDAQ:ILIU) announced its earnings results on Thursday. The company reported ($0.01) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.01), ARN reports. Interleukin Genetics, (NASDAQ:ILIU) opened ... [Published American Banking News - Forex - Aug 14 2014]
First reported Aug 06 2014 - Updated Aug 07 2014 - 1 reports

Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2014 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Wednesday, August 13, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s second quarter ... [Published Business Wire Health News - Aug 06 2014]
First reported May 14 2014 - Updated May 14 2014 - 3 reports

Interleukin Genetics Reports First Quarter 2014 Financial Results

WALTHAM, Mass.--(EON: Enhanced Online News)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal first quarter ended March 31, 2014. “We are proud to report the achievement of multiple milestones so far ... [Published EON Business - May 14 2014]
First reported May 07 2014 - Updated May 07 2014 - 1 reports

Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2014 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Wednesday, May 14, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s first quarter ... [Published Business Wire Health News - May 07 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Interleukin Genetics Secures Approval in New York State to Offer PerioPredict™

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test ... [Published Business Wire Health News - Apr 22 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Interleukin Genetics Publishes Additional Evidence for the PerioPredict™ Genetic Risk Test in Journal of Periodontal Research

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the pre-print online publication of its research study titled “Association of interleukin-1 gene variations with moderate to severe chronic periodontitis in multiple ... [Published Business Wire Health News - Apr 11 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 1 reports

Interleukin Genetics Announces Changes to Its Board of Directors

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced several changes to the Company’s Board of Directors. Joseph Landstra, Director of Finance at Alticor Corporate Enterprises, will join the Board as a Director, filling ... [Published Business Wire Health News - Mar 31 2014]

More Content

All (20) | News (8) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
TRACON Pharmaceuticals, Inc. : TRACON Pharmaceu... [Published Investegate - 14 hours ago]
TRACON Pharmaceuticals Completes and#36;27 Mill... [Published SPi World News - 15 hours ago]
TRACON Pharmaceuticals Completes $27 Million Fi... [Published Franklin Credit Management Corporation - 15 hours ago]
Interleukin Genetics to Participate in Upcoming... [Published CBS Detroit - 15 hours ago]
Interleukin Genetics to Participate in Upcoming... [Published Business Wire Health News - 15 hours ago]
Interleukin CFO bids adieu [Published Seeking Alpha - Aug 25 2014]
Interleukin Genetics Inc. Reports Second Quarte... [Published BioSpace - Aug 14 2014]
Interleukin Genetics, (ILIU) Releases Quarterly... [Published American Banking News - Forex - Aug 14 2014]
Interleukin Genetics Reports Second Quarter 201... [Published Business Wire Health News - Aug 13 2014]
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - Aug 06 2014]
Interleukin Genetics Reports First Quarter 2014... [Published EON Business - May 14 2014]
Interleukin Genetics Reports First Quarter 2014... [Published Business Wire Professional Services News - May 14 2014]
Interleukin Genetics Reports First Quarter 2014... [Published Business Wire Health News - May 14 2014]
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - May 07 2014]
Interleukin Genetics Secures Approval in New Yo... [Published Business Wire Health News - Apr 22 2014]
Interleukin Genetics Publishes Additional Evide... [Published Business Wire Health News - Apr 11 2014]
Interleukin Genetics Announces Changes to Its B... [Published Business Wire Health News - Mar 31 2014]
Interleukin Genetics Reports Fourth Quarter and... [Published Business Wire Health News - Mar 20 2014]
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - Mar 13 2014]
DNA-Based Dieting More Than Doubles Weight Loss... [Published PRWeb - Feb 10 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Interleukin Genetics to Participate in Upcoming... [Published Business Wire Health News - 15 hours ago]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that Dr. Kenneth S. Kornman, Chief Executive Officer, will participate in the following upcoming investor and scientific events: BTIG’s Inaugural Emerging Technologies ...
Interleukin Genetics Reports Second Quarter 201... [Published Business Wire Health News - Aug 13 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal second quarter ended June 30, 2014. “The utilization of our PerioPredict™ genetic test in the dental office is progressing ...
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - Aug 06 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Wednesday, August 13, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s second quarter ...
Interleukin Genetics Reports First Quarter 2014... [Published EON Business - May 14 2014]
WALTHAM, Mass.--(EON: Enhanced Online News)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal first quarter ended March 31, 2014. “We are proud to report the achievement of multiple milestones so far ...
Interleukin Genetics Reports First Quarter 2014... [Published Business Wire Professional Services News - May 14 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal first quarter ended March 31, 2014. “We are proud to report the achievement of multiple milestones so far in 2014, including ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.